CV Bonassi

Transcript

CV Bonassi

CURRICULUM VITAE
Name:
Birth date:
Stefano BONASSI
January, 3, 1956
Nationality:
Italian
Family:
Married with Angela Calvi since 1983 with four children
Position:
Head, Unit of Clinical and Molecular Epidemiology
IRCCS San Raffaele Pisana
Via di Val Cannuta, 247
00166 Rome
Tel. +39- 06-52253418; Fax +39-06-52255668
[email protected]
Home address:
Piazza Vittorio Veneto 6/6, I-16149 Genova - Italy
Tel. +390-10-418522
Education and specialty training:
Doctor in Biological Sciences - University of Genova (1981)
Specialist in Medical Statistics and Epidemiology - University of Pavia (1987)
In 2014 received from the Italian Ministry of Research the National Academic Qualification for full
Professor of Hygiene and Epidemiology (06/M1).
Research and professional experience
IRCCS San Raffaele Pisana – Rome.
Head, Unit of Clinical and Molecular Epidemiology (2009-to.present)
National Cancer Research Institute – Genova.
Junior research fellow (1981-1986)
Junior scientist (1987-1989)
Senior Scientist (1990-2000)
Head, Unit of Molecular Epidemiology (2000-2009)
University of Genoa – Genova.
Adjunct Professor of Molecular Epidemiology (2006-to present)
Istituto Giannina Gaslini (Children Hospital) – Genova, Italy
Consultant (1988-1989).
1
Italian League against Cancer,
Consultant (1984).
National Institute for Occupational Safety and Health (NIOSH) - Cincinnati, OH, USA.
Visiting Scientist (1985).
- Faculty for doctoral program in nutrition at the San Raffaele University in Rome, Italy
- Faculty for PhD and Masters programs in human genetics of the Universidad Autonoma de
Barcelona, Barcelona, Spain;
- M2E2 Master program Intenational courses of Molecular Epidemiology of Chronic diseases at
the Maastricht University, the Netherlands;
- Master in Epidemiology, Universita’ Cattolica del Sacro Cuore, Roma, Italy.
Consultant (Epidemiologist/Statistician) for
Janssen, Novartis, Menarini, Indena, Schwabe
National and International research grants (after 2000)
Associate investigator in research grants awarded by: the Italian Ministry of Health, Italian
Ministry for the Environment, Italian Association for Research on Cancer, Italian Research
Council, Liguria Region.
Italian Association for Research on Cancer (1998-2000) 105.000 €.
INAIL Valutazione di biomarker di instabilità genetica, danno ossidativo e lesioni precoci in
sangue, cellule esfoliate dalla mucosa boccale ed esalato bronchiale di lavoratori a rischioamianto’ (2011-2013) 190.000 €
INAIL Studio caso – controllo sui fattori di rischio familiari e diagnosi precoce della malattia di
Parkinson (2011-2013) 30.000 €
Ministero della salute Determination if lack of variabilità in cardiac r-r interval on EKG predicts
the development of the classic motor features of Parkinson’s disease (2011-2013) 30.000 €
Buzzi Foundation – Casale M. ‘Chemoprevention of environmentally induced genetic instability:
a randomized trial of NAC vs. placebo in a group of retired workers exposed to asbestos. As
Primary contractor (2008-2011) 150.000 €.
2
He has received support also from the NATO Life Science and Technology program, as Director
of Advanced Research Workshops (Lyon, 2001) and from the University of California-Berkeley
(2002).
Italian Space Agency Project: From Molecules to Man: WP ‘Genetic monitoring of astronauts’
(2006-2008) 336.723 €
Italian Ministry of Health ‘Multidisciplinary approach and phisical training in patients at high risk
of adverse cardiovascular events " (2006-2007) 24.000 €
Italian Ministry of Health ‘Identification of tumor biomarkers through a biology-driven integrated
approach " (2007-2009) 38.000 €
AIFA Therapeutic equivalence, bioequivalence and pharmacokinetic profile of the “generic”
levodopa/carbidopa preparation (HEXAL SpA) compared to the “originator” (Sinemet®), in
patients with fluctuating Parkinson’s disease. (2010-2012) 25.000 €
AIFA Effect of an integrated e-learning intervention, focused on Comprehensive Geriatric
Assessment to improve the quality of drug prescribing in hospitalized elderly
patients. (2009-2011) come SIGOT (20.000 € + 40.000 €)
AIFA Studio valutativo su efficacia di un intervento di formazione finalizzato al miglioramento
della prescrizione farmacologica in pazienti anziani in politerapia. (2012-2014) (as WP leader)
720.000 €
AIFA Pharmacological treatment in the elderly patient affected by cardiovascular diseases and
other chronic comorbidities: inappropriate prescribing and outcome evaluation among
institutionalized and community-dwelling elderly (2012-2014) 90.000 €
CCM Assistenza residenziale per gli anziani: costruzione e validazione di un sistema di
sorveglianza quality ed equity oriented (2010-2011) 50.000 €
Fondazione FORST Effectiveness of thermal water nasal inhalation and irrigation in
rhynopharyngitis and sinusitis (2013-2014) 90.000 €
Fondazione Umberto veronesi. Micronucleus frequency in exfoliated buccal cells as a biomarker
of DNA aging and risk for age-related diseases. (2013-2014) 25.000 €
European Community partnerships
BIOMED2 (Interaction of genetic and occupational factors) Concerted Action: "Assessments of
Predictive Value for Cancer of Cytogenetic Biomarkers Used in Health Surveillance of
Occupational Exposed Workers" as Primary Contractor (1995-2001) (50.000 €)
3
Fifth Framework Program (Quality of Life and Management of Living Resources) ‘Cytogenetic
biomarkers and human cancer risk’ as Primary Contractor (2001-2005) (240.000 €)
Extension to NAS (Newly Applicant States) of the program Quality of Life and Management of
Living Resources) ‘Cytogenetic biomarkers and human cancer risk’ as Primary Contractor
(2003-2005) (25.000 €)
Fifth Framework Program (Quality of Life and Management of living Resources) Key action 4:
Environment and Health ‘European Network on Children’s susceptibility and exposure to
environmental genotoxicants’ CHILDRENGENONETWORK as Primary Contractor (20032005) (30.000 €)
(FP7 - 2007-2013) Framework Programme for Research and Technological Development
SCRIPT Supervised Care and Rehabilitation involving personal tele-robotics. As Associate
researcher (2011-2014)
Objective 2013.5.1: Personalised Health, active ageing and independent living: eWall for Active
Long Living (eWALL) as Work package Leader (2013-2015)( 576.584 €)
Teacher of Epidemiological Methods in courses forPhD students and young investigators (after
2000):
Institute for Scientific Interchange, Turin (1999, 2000, 2001, 2002, 2003)
‘Ettore Majorana’ International Center for Scientific Culture, Erice (2000)
Italian Association of Epidemiology, Rome, (2000)
Environmental Mutagen Society, S.Diego, USA (2001)
Corso Avanzato di Radioprotezione Medica, INFN. Bressanone, (1999, 2001)
Environmental Mutagen Society, Anchorage, USA (2002)
The Alexander Hollander Course, Kracow, Poland (2002)
UC Berkeley - IARC Courses on Molecular Epidemiology, Berkeley, USA (2002)
Faculté de Mèdecine, Marseille, France (2003)
Universidad de los andes, Bogota’, Colombia (2004)
Environmental Muragen Society, San Francisco, USA (2005)
2nd Course of the International School of Bioelectromagnetics “Alessandro Chiabrera” on
Electromagnetic Fields and Genotoxicity. Erice, Italy (2005)
Universidad de los andes, Bogota’, Colombia (2006)
The Alexander Hollander Course, Valparaiso, Chile (2006)
Centro de Protección e Higiene de las Radiaciones, La Habana, Cuba (2007)
Alexander Hollaender course on genetic toxicology, Kolkata, India (2008)
Marie Curie Training Courses, University of Kuopio, Finland (2008)
The Alexander Hollaender Course, Astana (Kazchstan) (2009)
Universidad de LaPaz, LaPaz (Bolivia) February 2011
4
Porto University, Porto, Portugal. 15-20 May 2011
Maastricht University, Maastricht. Netherlands, 23-27 April 2012
UCSC, Rome, 3-5 May 2012
Maastricht University, Maastricht. Netherlands, 4-7 April 2013
UCSC, Rome, 24-25 May 2013
Alexander Hollander course, Asumption, Paraguay, 8-9 November 2013
Dr. Bonassi has supervised many specialization theses and postgraduate research projects at the
University of Genoa, and was part of the jury in PhD theses defense at the universities of
Marseille, Brussels, Copenhagen, and Porto.
Professional Society Membership
Italian Association of Epidemiology (AIE); Italian Society of Cancer Research (SIC); American
Association for Cancer Research (AACR); European Environmental Mutagen Society (EEMS),
SIGOT
US Environmental Mutagen Society (EMS) – Councilor (2001-2005)
Italian Environmental Mutagen Society (SIMA) – Councilor (2007-2009)
From 2009 to 2013 Dr. Bonassi has served as President of the International Association of Environmental
Mutagenesis and Genomics Societies (IAEMS) an international association with 6.000 members all over
the world (www.IAEMS.net)
Reviewer of the following journals:
International Journal of Cancer; Mutation Research; Reviews in Mutation Research; European
Journal of Public Health; Epidemiologia & Prevenzione (in Italian); Lancet; Alcoholism Clinical and Experimental Research; Mutagenesis; Cancer Epidemiology, Biomarkers &
Prevention; Carcinogenesis; The annals of Occupational Hygiene; Indian Journal of Cancer;
Cancer research; Toxicology and Applied Pharmacology; Genetics and Molecular Biology;
Genes, Chromosomes and Cancer; Chromosome Research; Journal National Cancer Institute;
Diabetes Research and Clinical Practice; The Journal of Clinical Endocrinology & Metabolism;
Circulation, Maturitas.
Dr. Stefano Bonassi is member of the editorial board of the following journals:
1. International Journal of Hygiene and Environmental Health,
2. Environmental & Molecular Mutagenesis,
3. Mutagenesis,
4. Cancer Epidemiology (former Cancer Detection and Prevention),
5. Revista Internacional de Contaminación Ambiental
6. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis.
5
He has been guest editor of special issues published by the journal Mutation Research and
Environmental and Molecular Mutagenesis.
Among the other references,
Dr. Bonassi has been member of the Ethics committee of the San Paolo Hospital of Savona, Italy
from 2000 to 2009 and is currently the biostatistician member of the IRCCS San Raffaele Pisana
ethics committee. He has been designated by the WHO/IPCS as a member of the Task Group of
European Experts on Biomarkers in Risk Assessment, and he is in the board of project reviewers
for the Italian Minister of Education, University and Scientific research (MIUR), for the Minister
of Health, for the Piedmont Region (CIPE), for the Minister of Health of Colombia (Colciencias),
Qatar (QNRF), and Ecuador (Senescyt), France (CNRS). He has been scientific advisor for
European organizations such as ECETOC (European Centre for Ecotoxicology and Toxicology of
Chemicals), pharmaceutical companies, euch as NOVARTIS; and charities such as Cancer
Research UK. Dr. Bonassi is included as a national expert in the EU Data Project of the Joint
Programming Initiative “More Years, better Lives”.
In his private life Dr. Bonassi is the president of a charity which promotes and support children
fostering (Il Nodo www.il-nodo.it)
6
After a first period as occupational and environmental epidemiologist his main scientific interest
soon shifted toward molecular epidemiology and the use of biomarkers in human population
studies an dclinical trials. In particular he was actively involved in assessing the role of
chromosomal damage in the early stages of carcinogenesis and the possible use of biomarkers of
DNA damage to predict cancer occurrence. Other topics of interest are the development of
epidemiological and statistical methods in population studies, and the validation of alternative
sources of tissue for biomarkers. Coordinator of the Italian side of the European Study Group on
Cytogenetic Biomarkers and Health (ESCH) and member of the steering committee of the
International Collaborative Project on Micronucleus Frequency in Human Populations (HUMN).
He is focused his research on the use of high throughput tecniques in population studies and in
clinical series to assess gene expression profile and genotype to identify subjects at risk or to
validate diagnostic/prognostic biomarker.
After working for several years as the chief of the Unit of Molecular Epidemiology at the
National Cancer Reseacrh Institute in Genoa he moved to Rome, to lead the unit of Clinical and
Molecular Epidemiology, with a commitment oriented mostly to clinical research and an interest
extended to cardiovascular diseases, neurodegenerative disorders, and physical rehabilitation. In
his new appointment he has participated to clinical researches in different rehabilitation settings,
e.g., cardiologic, respiratory, and neurological. He hast started two extensive platforms of COPD
and schyzofrenic patients to generate studies of systems medicine. These studies include a
structured tissues biorepository. Finally, he is involved in researches in geriatrics, mostly
addressing issues dealing with the appropriateness of drug prescription in elderly, but also several
other issues involved with aging and frailty. This year he started together with Prof. Andrew
Collins the ComNet project, an international collaborative project on the Comet assay (DNA
damage and repair) involving more than 100 laboratories all over the world.
7
Invited speaker to the following meetings (since 2000):
7th International Conference on Mechanisms of Antimutagenesis & Anticarcinogenesis.
Grand Rapids, Michigan, USA. 23-27 September 2000.
39th Annual Meeting of European Enviromental Mutagen Society.
Budapest, Hungary. 22-26 August, 2000.
XXIV Riunione scientifica annuale. Associazione Italiana di Epidemiologia.
Rome, Italy. 22-24 October, 2000.
32th Annual Meeting of the Environmental Mutagen Society.
San Diego, USA. 16-21 March, 2001.
8th International Conference of Environmental Mutagen Societies
Shizuoka, Japan 21-26 October, 2001
Cancer Research Methods Workshop – NIOSH
Washington, USA, 8-9 May, 2002
Molecular Epidemiology in Preventive medicine: Achievements and new challenges.
Kracow, Poland, 20-22 June 2002
2nd INTAS Meeting
Capri, Italy, 11-13 June 2002
Molecular and Genetic Epidemiology of Cancer (AACR Special meetings)
Kailua-Kona, USA, 18-23 January 2003
Workshop on advances in Human Research, Exposure and Risk Assessment related to
Reproductive and Developmental Effects.
Prague, Czech Republic, 17-20 March, 2003
4th International Conference on Environmental Mutagenesis in Human Populations
Florianopolis, SC – Brazil, 4-8 May, 2003.
International meeting on Chromosomal aberration
Essen, Germany, 10-13 September, 2003
Prevention des cancer professionnels
Europole de l’arbois, Marseille – France, 2-3 December 2003
ICT X Satellite meeting in Molecular Epidemiology
Porvoo, Finland, 8-10 July, 2004
8
International Symposium on Preventive Oncology
Nice, France, 8-11 February, 2004.
III Congreso Internacional de Genetica
Barranquilla, Colombia, 18-20 February 2004
9° International Conference on Environmental Mutagens
San Francisco, USA, 4-6 September 2005.
5th European Cytogenetics Conference
Madrid, Spain, 4-7 June 2005.
7th International Conference on DNA Repair
St. Andrews, UK, 5-6 June 2005.
36th European Environmental Mutagens Society
Prague, Czech Republic, 2-6 July 2006
Turkish Society of Toxicology
Antalya, Turkey, 1-5 November 2006
Minesseminarium For Lars Hagmar
Lund, Sweden, 26th November 2006
Belgian Society for Toxicology and Ecotoxicology
Leuven, Belgium, 1st December 2006
5th International conference on Environmental Mutagens in Human Populations
Antalya, Turkey, 20-24 May 2007
Risk-RAD Workshop on Chromosome aberrations and telomeres in carcinogenesis
Paris, France, 7-8 June 2007
VII Congreso LatinoAmericano de Mutagenesis, Carcinogenesis, y Teratogenesis
Cartagena, Colombia, 29-31 August 2007
The 8th International Symposium on Chromosome Aberrations
Awaji Island, Hyogo, Japan, 4-6 October 2007
3rd Asia-Pacific Nutrigenomics conference: Diet-gene interaction in human health and disease
Melbourne, Australia, 6-9 May 2008
14th Alexander Hollaender course. Workshop on arsenic exposure assessment
9
Kolkata, India 10-12 December 2008
3rd Meeting of ECNIS Network of Excellence. Role of gender in chromosome damage
Bruxelles 17 March 2009
Annual Meeting of Spaniish EMS
Barcelona, 29 June- 1 July 2009
Dutch Society of Toxicology. 30th Annual meeting The future starts now – innovative toxicity
testing
Veldhoven, The Netherlands 18-19 June 2009
9th International meeting onChromosomal aberrations (ISCA)
Rheinfels Castle, Germany 11-12 July 2009
15th Alexander Hollaender course. Genome environment interactions and genetic toxicology
Astana, Kazakhstan 23-26 September 2009
Brazilian Society of Genotoxicology
Ouro Preto (Mingas gerais), Brazil 9-15 November 2009
AQUATRAIN FINAL conference
Orleans, Paris. 7-8 July 2010
ICMAA and Nutrigenomics 2010
Guaruja’ (Brazil) 25-29 Septmber 2010
2nd AEMS
Bangkok (Thailand) 14-18 December 2010
Workshop on: Risk Perception of Nanotechnologies and Early Warning Systems.
Berlin (Germany) 24-25 May 2011
International Societ of Geriatric Oncology
Paris (France) 3-5 November 2011
Workshop on Nanotechnology (NANOLINEN Project)
Paris (France) 14-15 December 2011
Workshop: Exposure to nanoparticles in human populations: Immune system biomarkers in vitro
and in vivo
St.Christoph/Arlberg (Austria), 26 - 29 february, 2012
VIth International Conference on Environmental Mutagens in Human Populations.
10
Doha, Qatar, 25-29 March 2012
NanoLINEN Workshop
Antalya, Turkey, 26-29 April 2012
32nd annual meeting of the French Society of Mutragenesis and Genotoxicology
Rennes, France, 24-25 May 2012
2nd AAEMS conference.
Hangtzou, China, 19-23 October 2012
International Conference of Toxicology
Seoul, Korea, 1-4 July 2013
XI ICEM
Foz de Iguassu, Brazil, 1-4 November 2013
31th European Respiratory Society
Munich, 1-4 September 2014
Seminars (since 2000):
Le aberrazioni cromosomiche come test predittivo nella cancerogenesi.
Laboratori Nazionali di Frascati. Frascati, Italy. 18 January 2000.
Validation of biomarkers as early predictors of cancer
MSKCC, New York, USA. 7 May, 2002
Chromosomomal Aberration and risk of cancer in humans
RERF, Hiroshima, Japan. 22 March, 2004
Environmental and Molecular Epidemiology of Cancer
Universidad de los Andes, Bogota’, Colombia, 16 February 2004
Molecular Epidemiology of Cancer
Colciencias, Bogota’, Colombia, 24 May 2006
11
Game theory for the analysis of data from high throughput assays
Vrje University, Bruxelles, Belgium 27 November 2008
Molecular Epidemiology
Sant Ander University, La Paz,, Bolivia, April 2011.
12
Publications
Papers published by Stefano Bonassi have been cited 10900 times with a h index = 52
(Scholar).
1: Massimo L, Rossoni N, Mattei F, Bonassi S, Caprino D. Needs and expectations
of adolescent in-patients: the experience of Gaslini Children's Hospital. Int J
Adolesc Med Health. 2015 Jan 23. pii:
/j/ijamh.ahead-of-print/ijamh-2014-0070/ijamh-2014-0070.xml. doi:
10.1515/ijamh-2014-0070. [Epub ahead of print] PubMed PMID: 25720045.
2: Sánchez-Flores M, Pásaro E, Bonassi S, Laffon B, Valdiglesias V. γH2AX assay
as DNA damage biomarker for human population studies: defining experimental
conditions. Toxicol Sci. 2015 Apr;144(2):406-13. doi: 10.1093/toxsci/kfv011. Epub
2015 Jan 22. PubMed PMID: 25616596.
3: Neri M, Frustaci A, Milic M, Valdiglesias V, Fini M, Bonassi S, Barbanti P. A
meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway
in migraine. Cephalalgia. 2015 Jan 8. pii: 0333102414564888. [Epub ahead of
print] PubMed PMID: 25573894.
4: Neri M, Milazzo D, Ugolini D, Milic M, Campolongo A, Pasqualetti P, Bonassi S.
Worldwide interest in the comet assay: a bibliometric study. Mutagenesis. 2015
Jan;30(1):155-63. doi: 10.1093/mutage/geu061. PubMed PMID: 25527738.
5: Ugolini D, Bonassi S, Cristaudo A, Leoncini G, Ratto GB, Neri M. Temporal
trend, geographic distribution, and publication quality in asbestos research.
Environ Sci Pollut Res Int. 2015 May;22(9):6957-67. doi:
10.1007/s11356-014-3925-1. Epub 2014 Dec 6. PubMed PMID: 25475619.
6: Gison A, Rizza F, Bonassi S, Dall'Armi V, Lisi S, Giaquinto S. The
sense-of-coherence predicts health-related quality of life and emotional distress
but not disability in Parkinson's disease. BMC Neurol. 2014 Oct 10;14:193. doi:
10.1186/s12883-014-0193-0. PubMed PMID: 25304029; PubMed Central PMCID:
PMC4197289.
7: Marzetti E, Lorenzi M, Antocicco M, Bonassi S, Celi M, Mastropaolo S, Settanni
S, Valdiglesias V, Landi F, Bernabei R, Onder G. Shorter telomeres in peripheral
blood mononuclear cells from older persons with sarcopenia: results from an
exploratory study. Front Aging Neurosci. 2014 Aug 28;6:233. doi:
10.3389/fnagi.2014.00233. eCollection 2014. PubMed PMID: 25221511; PubMed Central
PMCID: PMC4147848.
8: Aleksovska K, Leoncini E, Bonassi S, Cesario A, Boccia S, Frustaci A.
13
Systematic review and meta-analysis of circulating S100B blood levels in
schizophrenia. PLoS One. 2014 Sep 9;9(9):e106342. doi:
10.1371/journal.pone.0106342. eCollection 2014. Review. PubMed PMID: 25202915;
PubMed Central PMCID: PMC4159239.
9: Cesario A, Auffray C, Agusti A, Apolone G, Balling R, Barbanti P, Bellia A,
Boccia S, Bousquet J, Cardaci V, Cazzola M, Dall'Armi V, Daraselia N, Ros LD,
Bufalo AD, Ducci G, Ferri L, Fini M, Fossati C, Gensini G, Granone PM, Kinross J,
Lauro D, Cascio GL, Lococo F, Lococo A, Maier D, Marcus F, Margaritora S, Marra
C, Minati G, Neri M, Pasqua F, Pison C, Pristipino C, Roca J, Rosano G, Rossini
PM, Russo P, Salinaro G, Shenhar S, Soreq H, Sterk PJ, Stocchi F, Torti M,
Volterrani M, Wouters EF, Frustaci A, Bonassi S. A systems medicine clinical
platform for understanding and managing non- communicable diseases. Curr Pharm
Des. 2014;20(38):5945-56. PubMed PMID: 24641232.
10: Costa C, García-Lestón J, Costa S, Coelho P, Silva S, Pingarilho M,
Valdiglesias V, Mattei F, Dall'Armi V, Bonassi S, Laffon B, Snawder J, Teixeira
JP. Is organic farming safer to farmers' health? A comparison between organic and
traditional farming. Toxicol Lett. 2014 Oct 15;230(2):166-76. doi:
10.1016/j.toxlet.2014.02.011. Epub 2014 Feb 24. PubMed PMID: 24576785.
11: Coelho P, García-Lestón J, Costa S, Costa C, Silva S, Fuchs D, Geisler S,
Dall'Armi V, Zoffoli R, Bonassi S, Pásaro E, Laffon B, Teixeira JP. Immunological
alterations in individuals exposed to metal(loid)s in the Panasqueira mining
area, Central Portugal. Sci Total Environ. 2014 Mar 15;475:1-7. doi:
10.1016/j.scitotenv.2013.12.093. Epub 2014 Jan 11. PubMed PMID: 24419281.
12: Kirsch-Volders M, Bonassi S, Knasmueller S, Holland N, Bolognesi C, Fenech
MF. Commentary: critical questions, misconceptions and a road map for improving
the use of the lymphocyte cytokinesis-block micronucleus assay for in vivo
biomonitoring of human exposure to genotoxic chemicals-a HUMN project
perspective. Mutat Res Rev Mutat Res. 2014 Jan-Mar;759:49-58. doi:
10.1016/j.mrrev.2013.12.001. Epub 2014 Jan 8. PubMed PMID: 24412600.
13: Franchi C, Mari D, Tettamanti M, Pasina L, Djade CD, Mannucci PM, Onder G,
Bernabei R, Gussoni G, Bonassi S, Nobili A; ELICADHE Investigators. E-learning to
improve the drug prescribing in the hospitalized elderly patients: the ELICADHE
feasibility pilot study. Aging Clin Exp Res. 2014 Aug;26(4):435-43. doi:
10.1007/s40520-013-0187-6. Epub 2013 Dec 17. PubMed PMID: 24343853.
14: Posteraro B, Persiani R, Dall'Armi V, Biondi A, Arzani D, Sicoli F, Bonassi
S, D'Ugo D, Ricciardi W, Boccia S. Prognostic factors and outcomes in Italian
patients undergoing curative gastric cancer surgery. Eur J Surg Oncol. 2014
Mar;40(3):345-51. doi: 10.1016/j.ejso.2013.11.002. Epub 2013 Nov 12. PubMed PMID:
14
24268760.
15: Collins A, Koppen G, Valdiglesias V, Dusinska M, Kruszewski M, Møller P,
Rojas E, Dhawan A, Benzie I, Coskun E, Moretti M, Speit G, Bonassi S; ComNet
project. The comet assay as a tool for human biomonitoring studies: the ComNet
project. Mutat Res Rev Mutat Res. 2014 Jan-Mar;759:27-39. doi:
10.1016/j.mrrev.2013.10.001. Epub 2013 Oct 31. Review. PubMed PMID: 24184488.
16: Ranzi A, Fustinoni S, Erspamer L, Campo L, Gatti MG, Bechtold P, Bonassi S,
Trenti T, Goldoni CA, Bertazzi PA, Lauriola P. Biomonitoring of the general
population living near a modern solid waste incinerator: a pilot study in Modena,
Italy. Environ Int. 2013 Nov;61:88-97. doi: 10.1016/j.envint.2013.09.008. Epub
2013 Oct 5. PubMed PMID: 24103350.
17: Coelho P, García-Lestón J, Costa S, Costa C, Silva S, Dall'Armi V, Zoffoli R,
Bonassi S, de Lima JP, Gaspar JF, Pásaro E, Laffon B, Teixeira JP. Genotoxic
effect of exposure to metal(loid)s. A molecular epidemiology survey of
populations living and working in Panasqueira mine area, Portugal. Environ Int.
2013 Oct;60:163-70. doi: 10.1016/j.envint.2013.08.014. Epub 2013 Sep 13. PubMed
PMID: 24036326.
18: Coelho P, Costa S, Costa C, Silva S, Walter A, Ranville J, Pastorinho MR,
Harrington C, Taylor A, Dall'Armi V, Zoffoli R, Candeias C, da Silva EF, Bonassi
S, Laffon B, Teixeira JP. Biomonitoring of several toxic metal(loid)s in
different biological matrices from environmentally and occupationally exposed
populations from Panasqueira mine area, Portugal. Environ Geochem Health. 2014
Apr;36(2):255-69. doi: 10.1007/s10653-013-9562-7. Epub 2013 Aug 30. PubMed PMID:
23990171.
19: Volterrani M, Iellamo F, Rosano G, Guarini P, Pusineri E, Bonassi S, Chimini
C, Zaccà F, Proto C; SICOA (Società Italiana Cardiologia Ospedalità Accreditata)
Investigators. Anticoagulation in "real world" patients with atrial fibrillation
in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione
Atriale) survey study. Int J Cardiol. 2013 Oct 12;168(5):4729-33. doi:
10.1016/j.ijcard.2013.07.169. Epub 2013 Jul 26. PubMed PMID: 23948115.
20: Tucker JD, Vadapalli M, Joiner MC, Ceppi M, Fenech M, Bonassi S. Estimating
the lowest detectable dose of ionizing radiation by the cytokinesis-block
micronucleus assay. Radiat Res. 2013 Sep;180(3):284-91. doi: 10.1667/RR3346.1.
Epub 2013 Aug 9. PubMed PMID: 23931722.
21: Onder G, Bonassi S, Abbatecola AM, Folino-Gallo P, Lapi F, Marchionni N, Pani
L, Pecorelli S, Sancarlo D, Scuteri A, Trifirò G, Vitale C, Zuccaro SM, Bernabei
R, Fini M; Geriatrics Working Group of the Italian Medicines Agency. High
15
prevalence of poor quality drug prescribing in older individuals: a nationwide
report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci.
2014 Apr;69(4):430-7. doi: 10.1093/gerona/glt118. Epub 2013 Aug 2. PubMed PMID:
23913935.
22: Bonassi S, Taioli E, Vermeulen R. Omics in population studies: a molecular
epidemiology perspective. Environ Mol Mutagen. 2013 Aug;54(7):455-60. doi:
10.1002/em.21805. Epub 2013 Aug 1. PubMed PMID: 23908054.
23: Cadby G, Mukherjee S, Musk AW, Reid A, Garlepp M, Dick I, Robinson C, Hui J,
Fiorito G, Guarrera S, Beilby J, Melton PE, Moses EK, Ugolini D, Mirabelli D,
Bonassi S, Magnani C, Dianzani I, Matullo G, Robinson B, Creaney J, Palmer LJ. A
genome-wide association study for malignant mesothelioma risk. Lung Cancer. 2013
Oct;82(1):1-8. doi: 10.1016/j.lungcan.2013.04.018. Epub 2013 Jul 1. PubMed PMID:
23827383.
24: Volterrani M, Iellamo F, Rosano G, Guarini P, Pusineri E, Bonassi S, Chimini
C, Zaccà F, Proto C; SICOA (Società Italiana Cardiologia Ospedalità Accreditata)
Investigators. On-target antihypertensive treatment in Italy: the ISPIT (Indagine
Sicoa Paziente Iperteso a Target) survey study. Int J Cardiol. 2013 Oct
9;168(4):4403-5. doi: 10.1016/j.ijcard.2013.05.040. Epub 2013 Jun 6. PubMed PMID:
23746462.
25: Matullo G, Guarrera S, Betti M, Fiorito G, Ferrante D, Voglino F, Cadby G, Di
Gaetano C, Rosa F, Russo A, Hirvonen A, Casalone E, Tunesi S, Padoan M, Giordano
M, Aspesi A, Casadio C, Ardissone F, Ruffini E, Betta PG, Libener R, Guaschino R,
Piccolini E, Neri M, Musk AW, de Klerk NH, Hui J, Beilby J, James AL, Creaney J,
Robinson BW, Mukherjee S, Palmer LJ, Mirabelli D, Ugolini D, Bonassi S, Magnani
C, Dianzani I. Genetic variants associated with increased risk of malignant
pleural mesothelioma: a genome-wide association study. PLoS One. 2013 Apr
23;8(4):e61253. doi: 10.1371/journal.pone.0061253. Print 2013. PubMed PMID:
23626673; PubMed Central PMCID: PMC3634031.
26: Fenech M, Kirsch-Volders M, Rossnerova A, Sram R, Romm H, Bolognesi C,
Ramakumar A, Soussaline F, Schunck C, Elhajouji A, Anwar W, Bonassi S. HUMN
project initiative and review of validation, quality control and prospects for
further development of automated micronucleus assays using image cytometry
systems. Int J Hyg Environ Health. 2013 Aug;216(5):541-52. doi:
10.1016/j.ijheh.2013.01.008. Epub 2013 Mar 16. Review. PubMed PMID: 23507632.
27: Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S. γH2AX as a marker of
DNA double strand breaks and genomic instability in human population studies.
Mutat Res. 2013 Jul-Sep;753(1):24-40. doi: 10.1016/j.mrrev.2013.02.001. Epub 2013
Feb 13. Review. PubMed PMID: 23416207.
16
28: Pasqua F, Alesii A, Geraneo K, Di Toro S, La Torre G, Sferrazza A, Mastrullo
MG, Calzetta L, Bonassi S, Cardaci V, Cesario A. A pilot survey on the quality of
life in respiratory rehabilitation carried out in COPD patients with severe
respiratory failure: preliminary data of a novel Inpatient Respiratory
Rehabilitation Questionnaire (IRRQ). Multidiscip Respir Med. 2012 Nov 20;7(1):46.
doi: 10.1186/2049-6958-7-46. PubMed PMID: 23168213; PubMed Central PMCID:
PMC3537560.
29: Stigliani S, Coco S, Moretti S, Oberthuer A, Fischer M, Theissen J, Gallo F,
Garavent A, Berthold F, Bonassi S, Tonini GP, Scaruffi P. High genomic
instability predicts survival in metastatic high-risk neuroblastoma. Neoplasia.
2012 Sep;14(9):823-32. PubMed PMID: 23019414; PubMed Central PMCID: PMC3459278.
30: Di Gaetano C, Voglino F, Guarrera S, Fiorito G, Rosa F, Di Blasio AM, Manzini
P, Dianzani I, Betti M, Cusi D, Frau F, Barlassina C, Mirabelli D, Magnani C,
Glorioso N, Bonassi S, Piazza A, Matullo G. An overview of the genetic structure
within the Italian population from genome-wide data. PLoS One. 2012;7(9):e43759.
doi: 10.1371/journal.pone.0043759. Epub 2012 Sep 12. PubMed PMID: 22984441;
31: Ugolini D, Neri M, Bennati L, Canessa PA, Casanova G, Lando C, Leoncini G,
Marroni P, Parodi B, Simonassi C, Bonassi S. CREST biorepository for
translational studies on malignant mesothelioma, lung cancer and other
respiratory tract diseases: Informatics infrastructure and standardized
annotation. Exp Ther Med. 2012 Mar;3(3):540-546. Epub 2011 Dec 14. PubMed PMID:
32: Ugolini D, Neri M, Cesario A, Marazzi G, Milazzo D, Volterrani M, Bennati L,
Bonassi S, Pasqualetti P. Bibliometric analysis of literature in cerebrovascular
and cardiovascular diseases rehabilitation: growing numbers, reducing impact
factor. Arch Phys Med Rehabil. 2013 Feb;94(2):324-31. doi:
10.1016/j.apmr.2012.08.205. Epub 2012 Aug 23. PubMed PMID: 22922328.
33: Sterzi S, Cesario A, Cusumano G, Corbo G, Lococo F, Biasotti B, Lapenna LM,
Magrone G, Dall'armi V, Meacci E, Porziella V, Bonassi S, Margaritora S, Granone
P. How best to assess the quality of life in long-term survivors after surgery
for NSCLC? Comparison between clinical predictors and questionnaire scores. Clin
Lung Cancer. 2013 Jan;14(1):78-87. doi: 10.1016/j.cllc.2012.04.002. Epub 2012 May
17. PubMed PMID: 22607778.
34: Collins A, Anderson D, Coskun E, Dhawan A, Dusinska M, Koppen G, Kruszewski
M, Moretti M, Rojas E, Speit G, Valverde M, Bonassi S. Launch of the ComNet
(comet network) project on the comet assay in human population studies during the
17
International Comet Assay Workshop meeting in Kusadasi, Turkey (September 13-16,
2011). Mutagenesis. 2012 Jul;27(4):385-6. doi: 10.1093/mutage/ges014. Epub 2012
May 6. PubMed PMID: 22564849.
35: Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B,
Bonassi S. Oxidative stress-related biomarkers in autism: systematic review and
meta-analyses. Free Radic Biol Med. 2012 May 15;52(10):2128-41. doi:
10.1016/j.freeradbiomed.2012.03.011. Epub 2012 Apr 18. Review. PubMed PMID:
22542447.
36: Barbanti P, Fofi L, Dall'Armi V, Aurilia C, Egeo G, Vanacore N, Bonassi S.
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a
double-blind trial. J Headache Pain. 2012 Jul;13(5):407-14. doi:
10.1007/s10194-012-0440-y. Epub 2012 Mar 30. PubMed PMID: 22460943; PubMed
Central PMCID: PMC3381061.
37: Dusinska M, Staruchova M, Horska A, Smolkova B, Collins A, Bonassi S,
Volkovova K. Are glutathione S transferases involved in DNA damage signalling?
Interactions with DNA damage and repair revealed from molecular epidemiology
studies. Mutat Res. 2012 Aug 1;736(1-2):130-7. doi: 10.1016/j.mrfmmm.2012.03.003.
Epub 2012 Mar 20. PubMed PMID: 22450146.
38: Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR,
Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P,
Brennan P, Brenner H, Duell EJ, Fabianova E, Field JK, Foretova L, Friis S,
Harris CC, Holcatova I, Hong YC, Isla D, Janout V, Kiemeney LA, Kiyohara C, Lan
Q, Lazarus P, Lissowska J, Le Marchand L, Mates D, Matsuo K, Mayordomo JI,
McLaughlin JR, Morgenstern H, Müeller H, Orlow I, Park BJ, Pinchev M, Raji OY,
Rennert HS, Rudnai P, Seow A, Stucker I, Szeszenia-Dabrowska N, Dawn Teare M,
Tjønnelan A, Ugolini D, van der Heijden HF, Wichmann E, Wiencke JK, Woll PJ, Yang
P, Zaridze D, Zhang ZF, Etzel CJ, Hung RJ. Increased risk of lung cancer in
individuals with a family history of the disease: a pooled analysis from the
International Lung Cancer Consortium. Eur J Cancer. 2012 Sep;48(13):1957-68. doi:
10.1016/j.ejca.2012.01.038. Epub 2012 Mar 19. PubMed PMID: 22436981; PubMed
39: Neri M, Ugolini D, Boccia S, Canessa PA, Cesario A, Leoncini G, Mutti L,
Bonassi S. Chemoprevention of asbestos-linked cancers: a systematic review.
Anticancer Res. 2012 Mar;32(3):1005-13. Review. PubMed PMID: 22399624.
40: Pasqua F, D'Angelillo R, Mattei F, Bonassi S, Biscione GL, Geraneo K, Cardaci
V, Ferri L, Ramella S, Granone P, Sterzi S, Crisafulli E, Clini E, Lococo F,
Trodella L, Cesario A. Pulmonary rehabilitation following radical chemo-radiation
in locally advanced non surgical NSCLC: Preliminary evidences. Lung Cancer. 2012
18
May;76(2):258-9. doi: 10.1016/j.lungcan.2012.01.015. Epub 2012 Mar 2. PubMed
PMID: 22386840.
41: Neri M, Bonassi S, Russo P. Genetic variations in CHRNA7 or CHRFAM7 and
susceptibility to dementia. Curr Drug Targets. 2012 May;13(5):636-43. Review.
PubMed PMID: 22300029.
42: Morandi F, Scaruffi P, Gallo F, Stigliani S, Moretti S, Bonassi S, Gambini C,
Mazzocco K, Fardin P, Haupt R, Arcamone G; Italian Cooperative Group for
Neuroblastoma, Pistoia V, Tonini GP, Corrias MV. Bone marrow-infiltrating human
neuroblastoma cells express high levels of calprotectin and HLA-G proteins. PLoS
One. 2012;7(1):e29922. doi: 10.1371/journal.pone.0029922. Epub 2012 Jan 9. PubMed
PMID: 22253825; PubMed Central PMCID: PMC3253802.
43: Franceschini M, Ceravolo MG, Agosti M, Cavallini P, Bonassi S, Dall'Armi V,
Massucci M, Schifini F, Sale P. Clinical relevance of action observation in
upper-limb stroke rehabilitation: a possible role in recovery of functional
dexterity. A randomized clinical trial. Neurorehabil Neural Repair. 2012
Jun;26(5):456-62. doi: 10.1177/1545968311427406. Epub 2012 Jan 10. PubMed PMID:
22235059.
44: Coco S, Theissen J, Scaruffi P, Stigliani S, Moretti S, Oberthuer A, Valdora
F, Fischer M, Gallo F, Hero B, Bonassi S, Berthold F, Tonini GP. Age-dependent
accumulation of genomic aberrations and deregulation of cell cycle and telomerase
genes in metastatic neuroblastoma. Int J Cancer. 2012 Oct 1;131(7):1591-600. doi:
10.1002/ijc.27432. Epub 2012 Feb 18. PubMed PMID: 22234802.
45: Rosenberger A, Bickeböller H, McCormack V, Brenner DR, Duell EJ, Tjønneland
A, Friis S, Muscat JE, Yang P, Wichmann HE, Heinrich J, Szeszenia-Dabrowska N,
Lissowska J, Zaridze D, Rudnai P, Fabianova E, Janout V, Bencko V, Brennan P,
Mates D, Schwartz AG, Cote ML, Zhang ZF, Morgenstern H, Oh SS, Field JK, Raji O,
McLaughlin JR, Wiencke J, LeMarchand L, Neri M, Bonassi S, Andrew AS, Lan Q, Hu
W, Orlow I, Park BJ, Boffetta P, Hung RJ. Asthma and lung cancer risk: a
systematic investigation by the International Lung Cancer Consortium.
Carcinogenesis. 2012 Mar;33(3):587-97. doi: 10.1093/carcin/bgr307. Epub 2011 Dec
22. PubMed PMID: 22198214; PubMed Central PMCID: PMC3291861.
46: Scaruffi P, Morandi F, Gallo F, Stigliani S, Parodi S, Moretti S, Bonassi S,
Fardin P, Garaventa A, Zanazzo G, Pistoia V, Tonini GP, Corrias MV. Bone marrow
of neuroblastoma patients shows downregulation of CXCL12 expression and presence
of IFN signature. Pediatr Blood Cancer. 2012 Jul 15;59(1):44-51. doi:
10.1002/pbc.23339. Epub 2011 Oct 12. PubMed PMID: 21994039.
47: Borioni N, Marinaro P, Celestini S, Del Sole F, Magro R, Zoppi D, Mattei F,
19
Dall' Armi V, Mazzarella F, Cesario A, Bonassi S. Effect of equestrian therapy
and onotherapy in physical and psycho-social performances of adults with
intellectual disability: a preliminary study of evaluation tools based on the ICF
classification. Disabil Rehabil. 2012;34(4):279-87. doi:
10.3109/09638288.2011.605919. Epub 2011 Oct 12. PubMed PMID: 21988646.
48: Ugolini D, Neri M, Cesario A, Bonassi S, Milazzo D, Bennati L, Lapenna LM,
Pasqualetti P. Scientific production in cancer rehabilitation grows higher: a
bibliometric analysis. Support Care Cancer. 2012 Aug;20(8):1629-38. doi:
10.1007/s00520-011-1253-2. Epub 2011 Sep 1. PubMed PMID: 21881910.
49: Bonassi S, Coskun E, Ceppi M, Lando C, Bolognesi C, Burgaz S, Holland N,
Kirsh-Volders M, Knasmueller S, Zeiger E, Carnesoltas D, Cavallo D, da Silva J,
de Andrade VM, Demircigil GC, Domínguez Odio A, Donmez-Altuntas H, Gattas G, Giri
A, Giri S, Gómez-Meda B, Gómez-Arroyo S, Hadjidekova V, Haveric A, Kamboj M,
Kurteshi K, Martino-Roth MG, Montero Montoya R, Nersesyan A, Pastor-Benito S,
Favero Salvadori DM, Shaposhnikova A, Stopper H, Thomas P, Torres-Bugarín O,
Yadav AS, Zúñiga González G, Fenech M. The HUman MicroNucleus project on
eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors,
occupational exposures, health status, and assay protocol. Mutat Res. 2011
Nov-Dec;728(3):88-97. doi: 10.1016/j.mrrev.2011.06.005. Epub 2011 Jul 8. Review.
50: Peters S, Portengen L, Bonassi S, Sram R, Vermeulen R. Intra- and
interindividual variability in lymphocyte chromosomal aberrations: implications
for cancer risk assessment. Am J Epidemiol. 2011 Aug 15;174(4):490-3. doi:
10.1093/aje/kwr114. Epub 2011 Jun 7. PubMed PMID: 21652601.
51: Albino D, Brizzolara A, Moretti S, Falugi C, Mirisola V, Scaruffi P, Di
Candia M, Truini M, Coco S, Bonassi S, Tonini GP. Gene expression profiling
identifies eleven DNA repair genes down-regulated during mouse neural crest cell
migration. Int J Dev Biol. 2011;55(1):65-72. doi: 10.1387/ijdb.092970da. PubMed
PMID: 21425081.
52: Coco S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, Berthold
F, Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A, Tonini GP. Chromosome
9q and 16q loss identified by genome-wide pooled-analysis are associated with
tumor aggressiveness in patients with classic medulloblastoma. OMICS. 2011
May;15(5):273-80. doi: 10.1089/omi.2010.0103. Epub 2011 Feb 24. PubMed PMID:
21348762.
53: Cutolo M, Villaggio B, Brizzolara R, Montagna P, Gallo F, Moretti S, Bonassi
S, Sulli A, Soldano S. Identification and quantification of selected inflammatory
genes modulated by leflunomide and prednisone treatment in early rheumatoid
20
arthritis patients. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):72-9. Epub 2011 Feb
23. PubMed PMID: 21345295.
54: Vitale C, Marazzi G, Pelliccia F, Volterrani M, Cerquetani E, Spoletini I,
Mercuro G, Bonassi S, Dall'Armi V, Fini M, Rosano GM. Trimetazidine improves
exercise performance in patients with peripheral arterial disease. Pharmacol Res.
2011 Apr;63(4):278-83. doi: 10.1016/j.phrs.2011.01.003. Epub 2011 Jan 8. PubMed
PMID: 21220024.
55: Ceppi M, Gallo F, Bonassi S. Study design and statistical analysis of data in
human population studies with the micronucleus assay. Mutagenesis. 2011
Jan;26(1):247-52. doi: 10.1093/mutage/geq060. Review. PubMed PMID: 21164209.
56: Fenech M, Holland N, Zeiger E, Chang WP, Burgaz S, Thomas P, Bolognesi C,
Knasmueller S, Kirsch-Volders M, Bonassi S. The HUMN and HUMNxL international
collaboration projects on human micronucleus assays in lymphocytes and buccal
cells--past, present and future. Mutagenesis. 2011 Jan;26(1):239-45. doi:
10.1093/mutage/geq051. Review. PubMed PMID: 21164208.
57: Bonassi S, El-Zein R, Bolognesi C, Fenech M. Micronuclei frequency in
peripheral blood lymphocytes and cancer risk: evidence from human studies.
Mutagenesis. 2011 Jan;26(1):93-100. doi: 10.1093/mutage/geq075. Review. PubMed
PMID: 21164188.
58: Fenech M, Bonassi S. The effect of age, gender, diet and lifestyle on DNA
damage measured using micronucleus frequency in human peripheral blood
lymphocytes. Mutagenesis. 2011 Jan;26(1):43-9. doi: 10.1093/mutage/geq050.
Review. PubMed PMID: 21164181.
59: Dhillon VS, Thomas P, Iarmarcovai G, Kirsch-Volders M, Bonassi S, Fenech M.
Genetic polymorphisms of genes involved in DNA repair and metabolism influence
micronucleus frequencies in human peripheral blood lymphocytes. Mutagenesis. 2011
Jan;26(1):33-42. doi: 10.1093/mutage/geq076. Review. PubMed PMID: 21164180.
60: van Leeuwen DM, Pedersen M, Knudsen LE, Bonassi S, Fenech M, Kleinjans JC,
Jennen DG. Transcriptomic network analysis of micronuclei-related genes: a case
study. Mutagenesis. 2011 Jan;26(1):27-32. doi: 10.1093/mutage/geq074. Review.
61: Horska A, Mislanova C, Bonassi S, Ceppi M, Volkovova K, Dusinska M. Vitamin C
levels in blood are influenced by polymorphisms in glutathione S-transferases.
Eur J Nutr. 2011 Sep;50(6):437-46. doi: 10.1007/s00394-010-0147-2. Epub 2010 Dec
9. PubMed PMID: 21152927.
21
62: Cafarotti S, Dall'Armi V, Cusumano G, Margaritora S, Meacci E, Lococo F, Vita
ML, Porziella V, Bonassi S, Cesario A, Granone P. Small-bore wire-guided chest
drains: safety, tolerability, and effectiveness in pneumothorax, malignant
effusions, and pleural empyema. J Thorac Cardiovasc Surg. 2011 Mar;141(3):683-7.
doi: 10.1016/j.jtcvs.2010.08.044. Epub 2010 Oct 13. PubMed PMID: 20947099.
63: Moretti S, Fragnelli V, Patrone F, Bonassi S. Using coalitional games on
biological networks to measure centrality and power of genes. Bioinformatics.
2010 Nov 1;26(21):2721-30. doi: 10.1093/bioinformatics/btq508. Epub 2010 Sep 3.
64: Gee GV, Stanifer ML, Christensen BC, Atwood WJ, Ugolini D, Bonassi S, Resnick
MB, Nelson HH, Marsit CJ, Kelsey KT. SV40 associated miRNAs are not detectable in
mesotheliomas. Br J Cancer. 2010 Sep 7;103(6):885-8. doi: 10.1038/sj.bjc.6605848.
Epub 2010 Aug 17. PubMed PMID: 20717113; PubMed Central PMCID: PMC2966630.
65: Ugolini D, Neri M, Casilli C, Bonassi S. Development of search filters for
retrieval of literature on the molecular epidemiology of cancer. Mutat Res. 2010
Aug 30;701(2):107-10. doi: 10.1016/j.mrgentox.2010.05.016. Epub 2010 Jun 2.
66: Albertini G, Bonassi S, Dall'Armi V, Giachetti I, Giaquinto S, Mignano M.
Spectral analysis of the voice in Down Syndrome. Res Dev Disabil. 2010
Sep-Oct;31(5):995-1001. doi: 10.1016/j.ridd.2010.04.024. Epub 2010 May 20. PubMed
PMID: 20488659.
67: Cutolo M, Villaggio B, Pizzorni C, Paolino S, Moretti S, Gallo F, Bonassi S,
Sulli A, Seriolo B, Montagna P, Soldano S. Inflammatory gene profile in early
rheumatoid arthritis and modulation by leflunomide and prednisone treatment. Ann
N Y Acad Sci. 2010 Apr;1193:15-21. doi: 10.1111/j.1749-6632.2009.05297.x. PubMed
PMID: 20398002.
68: Margaritora S, Cesario A, Cusumano G, Cafarotti S, Corbo GM, Ferri L, Ceppi
M, Meacci E, Valente S, D'Angelillo RM, Russo P, Porziella V, Bonassi S, Pasqua
F, Sterzi S, Granone P. Is pulmonary function damaged by neoadjuvant lung cancer
therapy? A comprehensive serial time-trend analysis of pulmonary function after
induction radiochemotherapy plus surgery. J Thorac Cardiovasc Surg. 2010
Jun;139(6):1457-63. doi: 10.1016/j.jtcvs.2009.10.023. Epub 2010 Apr 2. PubMed
PMID: 20363001.
69: Scaruffi P, Stigliani S, Coco S, Valdora F, De Vecchi C, Bonassi S, Tonini
GP. Transcribed-ultra conserved region expression profiling from low-input total
RNA. BMC Genomics. 2010 Mar 3;11:149. doi: 10.1186/1471-2164-11-149. PubMed PMID:
22
70: Kirsch-Volders M, Bonassi S, Herceg Z, Hirvonen A, Möller L, Phillips DH.
Gender-related differences in response to mutagens and carcinogens. Mutagenesis.
2010 May;25(3):213-21. doi: 10.1093/mutage/geq008. Epub 2010 Mar 1. PubMed PMID:
20194421.
71: Ugolini D, Neri M, Casilli C, Ceppi M, Canessa PA, Ivaldi GP, Paganuzzi M,
Bonassi S. A bibliometric analysis of scientific production in mesothelioma
research. Lung Cancer. 2010 Nov;70(2):129-35. doi: 10.1016/j.lungcan.2010.01.013.
Epub 2010 Feb 18. PubMed PMID: 20170978.
72: Margaritora S, Cesario A, Cusumano G, Meacci E, D'Angelillo R, Bonassi S,
Carnassale G, Porziella V, Tessitore A, Vita ML, Lauriola L, Evoli A, Granone P.
Thirty-five-year follow-up analysis of clinical and pathologic outcomes of
thymoma surgery. Ann Thorac Surg. 2010 Jan;89(1):245-52; discussion 252. doi:
10.1016/j.athoracsur.2009.08.074. PubMed PMID: 20103246.
73: Scaruffi P, Stigliani S, Moretti S, Coco S, De Vecchi C, Valdora F, Garaventa
A, Bonassi S, Tonini GP. Transcribed-Ultra Conserved Region expression is
associated with outcome in high-risk neuroblastoma. BMC Cancer. 2009 Dec
15;9:441. doi: 10.1186/1471-2407-9-441. PubMed PMID: 20003513; PubMed Central
PMCID: PMC2804711.
74: Ceppi M, Biasotti B, Fenech M, Bonassi S. Human population studies with the
exfoliated buccal micronucleus assay: statistical and epidemiological issues.
Mutat Res. 2010 Jul-Sep;705(1):11-9. doi: 10.1016/j.mrrev.2009.11.001. Epub 2009
Nov 20. Review. PubMed PMID: 19932192.
75: Gemignani F, Neri M, Bottari F, Barale R, Canessa PA, Canzian F, Ceppi M,
Spitaleri I, Cipollini M, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Ugolini
D, Mutti L, Bonassi S, Landi S. Risk of malignant pleural mesothelioma and
polymorphisms in genes involved in the genome stability and xenobiotics
metabolism. Mutat Res. 2009 Dec 1;671(1-2):76-83. doi:
10.1016/j.mrfmmm.2009.09.003. Epub 2009 Sep 12. PubMed PMID: 19751749.
76: Cesario A, Dall'Armi V, Cusumano G, Ferri L, Margaritora S, Cardaci V,
Cafarotti S, Russo P, Paleari L, Sterzi S, Pasqua F, Bonassi S, Granone P.
Post-operative pulmonary rehabilitation after lung resection for NSCLC: a follow
up study. Lung Cancer. 2009 Nov;66(2):268-9. doi: 10.1016/j.lungcan.2009.08.002.
Epub 2009 Sep 1. PubMed PMID: 19726101.
77: Banelli B, Bonassi S, Casciano I, Mazzocco K, Di Vinci A, Scaruffi P, Brigati
C, Allemanni G, Borzì L, Tonini GP, Romani M. Outcome prediction and risk
assessment by quantitative pyrosequencing methylation analysis of the SFN gene in
23
advanced stage, high-risk, neuroblastic tumor patients. Int J Cancer. 2010 Feb
1;126(3):656-68. doi: 10.1002/ijc.24768. PubMed PMID: 19626586.
78: Bonassi S, Biasotti B, Kirsch-Volders M, Knasmueller S, Zeiger E, Burgaz S,
Bolognesi C, Holland N, Thomas P, Fenech M; HUMNXL Project Consortium. State of
the art survey of the buccal micronucleus assay--a first stage in the HUMN(XL)
project initiative. Mutagenesis. 2009 Jul;24(4):295-302. doi:
10.1093/mutage/gep019. Epub 2009 May 28. PubMed PMID: 19477934.
79: Thomas P, Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E,
Knasmueller S, Fenech M. Buccal micronucleus cytome assay. Nat Protoc.
2009;4(6):825-37. doi: 10.1038/nprot.2009.53. Epub 2009 May 7. PubMed PMID:
19444240.
80: Rossi AM, Hansteen IL, Skjelbred CF, Ballardin M, Maggini V, Murgia E, Tomei
A, Viarengo P, Knudsen LE, Barale R, Norppa H, Bonassi S. Association between
frequency of chromosomal aberrations and cancer risk is not influenced by genetic
polymorphisms in GSTM1 and GSTT1. Environ Health Perspect. 2009 Feb;117(2):203-8.
doi: 10.1289/ehp.11769. Epub 2008 Sep 1. PubMed PMID: 19270789; PubMed Central
PMCID: PMC2649221.
81: Filippi U, Brizzolara R, Venuti D, Cesarone A, Maritati VA, Podestà M, Yung
WF, Bottaro LC, Orselli A, Chiappori A, Schiavo M, Caputo M, Bonassi S, Bagnasco
M. Prevalence of post-partum thyroiditis in Liguria (Italy): an observational
study. J Endocrinol Invest. 2008 Dec;31(12):1063-8. PubMed PMID: 19246971.
82: Fenech M, Holland N, Knasmueller S, Burgaz S, Bonassi S. Report on the buccal
micronucleus assay workshop organized by the International Human Micronucleus
(HUMN) project--Antalya, Turkey 2007. Mutagenesis. 2009 Mar;24(2):199-201. doi:
10.1093/mutage/gen065. Epub 2008 Dec 4. PubMed PMID: 19056855.
83: Ugolini D, Neri M, Canessa PA, Casilli C, Catrambone G, Ivaldi GP, Lando C,
Marroni P, Paganuzzi M, Parodi B, Visconti P, Puntoni R, Bonassi S. The CREST
biorepository: a tool for molecular epidemiology and translational studies on
malignant mesothelioma, lung cancer, and other respiratory tract diseases. Cancer
Epidemiol Biomarkers Prev. 2008 Nov;17(11):3013-9. doi:
10.1158/1055-9965.EPI-08-0524. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009
Apr;18(4):1331. multiple author names corrected. PubMed PMID: 18990743.
84: Betti M, Neri M, Ferrante D, Landi S, Biava A, Gemignani F, Bertolotti M,
Mirabelli D, Padoan M, Ugolini D, Botta M, Bonassi S, Magnani C, Dianzani I.
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant
mesothelioma. Int J Hyg Environ Health. 2009 May;212(3):322-9. doi:
10.1016/j.ijheh.2008.08.001. Epub 2008 Oct 1. PubMed PMID: 18838334.
24
85: Moretti S, van Leeuwen D, Gmuender H, Bonassi S, van Delft J, Kleinjans J,
Patrone F, Merlo DF. Combining Shapley value and statistics to the analysis of
gene expression data in children exposed to air pollution. BMC Bioinformatics.
2008 Sep 2;9:361. doi: 10.1186/1471-2105-9-361. PubMed PMID: 18764936; PubMed
86: Albino D, Scaruffi P, Moretti S, Coco S, Truini M, Di Cristofano C, Cavazzana
A, Stigliani S, Bonassi S, Tonini GP. Identification of low intratumoral gene
expression heterogeneity in neuroblastic tumors by genome-wide expression
analysis and game theory. Cancer. 2008 Sep 15;113(6):1412-22. doi:
10.1002/cncr.23720. PubMed PMID: 18671248.
87: Iarmarcovai G, Ceppi M, Botta A, Orsière T, Bonassi S. Micronuclei frequency
in peripheral blood lymphocytes of cancer patients: a meta-analysis. Mutat Res.
2008 Sep-Oct;659(3):274-83. doi: 10.1016/j.mrrev.2008.05.006. Epub 2008 Jun 5.
88: Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, Knasmueller S,
Fenech M. The micronucleus assay in human buccal cells as a tool for
biomonitoring DNA damage: the HUMN project perspective on current status and
knowledge gaps. Mutat Res. 2008 Jul-Aug;659(1-2):93-108. doi:
10.1016/j.mrrev.2008.03.007. Epub 2008 Apr 11. Review. PubMed PMID: 18514568.
89: Neri M, Ugolini D, Dianzani I, Gemignani F, Landi S, Cesario A, Magnani C,
Mutti L, Puntoni R, Bonassi S. Genetic susceptibility to malignant pleural
mesothelioma and other asbestos-associated diseases. Mutat Res. 2008
Jul-Aug;659(1-2):126-36. doi: 10.1016/j.mrrev.2008.02.002. Epub 2008 Feb 23.
90: Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A,
Cebulska-Wasilewska A, Fabianova E, Fucic A, Gundy S, Hansteen IL, Knudsen LE,
Lazutka J, Rossner P, Sram RJ, Boffetta P. Chromosomal aberration frequency in
lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22
358 subjects in 11 countries. Carcinogenesis. 2008 Jun;29(6):1178-83. doi:
10.1093/carcin/bgn075. Epub 2008 Mar 19. PubMed PMID: 18356148; PubMed Central
PMCID: PMC2443275.
91: Murgia E, Ballardin M, Bonassi S, Rossi AM, Barale R. Validation of
micronuclei frequency in peripheral blood lymphocytes as early cancer risk
biomarker in a nested case-control study. Mutat Res. 2008 Mar 1;639(1-2):27-34.
Epub 2007 Nov 13. PubMed PMID: 18155071.
92: Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms
25
and micronucleus formation: a review of the literature. Mutat Res. 2008
Mar-Apr;658(3):215-33. Epub 2007 Oct 22. Review. PubMed PMID: 18037339.
93: Mateuca RA, Roelants M, Iarmarcovai G, Aka PV, Godderis L, Tremp A, Bonassi
S, Fenech M, Bergé-Lefranc JL, Kirsch-Volders M. hOGG1(326), XRCC1(399) and
XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes
in vivo. Mutagenesis. 2008 Jan;23(1):35-41. Epub 2007 Oct 29. PubMed PMID:
17971348.
94: Ugolini D, Neri M, Ceppi M, Cesario A, Dianzani I, Filiberti R, Gemignani F,
Landi S, Magnani C, Mutti L, Puntoni R, Bonassi S. Genetic susceptibility to
malignant mesothelioma and exposure to asbestos: the influence of the familial
factor. Mutat Res. 2008 Mar-Apr;658(3):162-71. Epub 2007 Aug 10. Review. PubMed
PMID: 17904414.
95: Fucić A, Znaor A, Strnad M, van der Hel O, Aleksandrov A, Miskov S, Grah J,
Sedlar M, Jazbec AM, Ceppi M, Vermeulen R, Boffetta P, Norppa H, Bonassi S.
Chromosome damage and cancer risk in the workplace: the example of cytogenetic
surveillance in Croatia. Toxicol Lett. 2007 Jul 30;172(1-2):4-11. Epub 2007 May
25. PubMed PMID: 17651925.
96: Bonassi S. [Depleted uranium: the Signum Project]. Epidemiol Prev. 2007
Jan-Feb;31(1):6. Italian. PubMed PMID: 17591395.
97: Ugolini D, Puntoni R, Perera FP, Schulte PA, Bonassi S. A bibliometric
analysis of scientific production in cancer molecular epidemiology.
Carcinogenesis. 2007 Aug;28(8):1774-9. Epub 2007 Jun 4. PubMed PMID: 17548902.
98: Cesario A, Ferri L, Galetta D, Cardaci V, Biscione G, Pasqua F, Piraino A,
Bonassi S, Russo P, Sterzi S, Margaritora S, Granone P. Pre-operative pulmonary
rehabilitation and surgery for lung cancer. Lung Cancer. 2007 Jul;57(1):118-9.
Epub 2007 May 1. PubMed PMID: 17475363.
99: Cesario A, Ferri L, Galetta D, Pasqua F, Bonassi S, Clini E, Biscione G,
Cardaci V, di Toro S, Zarzana A, Margaritora S, Piraino A, Russo P, Sterzi S,
Granone P. Post-operative respiratory rehabilitation after lung resection for
non-small cell lung cancer. Lung Cancer. 2007 Aug;57(2):175-80. Epub 2007 Apr 17.
100: Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, Canessa PA,
Canzian F, Ceppi M, Filiberti R, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP,
Mutti L, Puntoni R. Polymorphisms of glutathione-S-transferase M1 and manganese
superoxide dismutase are associated with the risk of malignant pleural
mesothelioma. Int J Cancer. 2007 Jun 15;120(12):2739-43. PubMed PMID: 17290392.
26
101: Fardin P, Moretti S, Biasotti B, Ricciardi A, Bonassi S, Varesio L.
Normalization of low-density microarray using external spike-in controls:
analysis of macrophage cell lines expression profile. BMC Genomics. 2007 Jan
17;8:17. PubMed PMID: 17229315; PubMed Central PMCID: PMC1797020.
102: Iarmarcovai G, Bonassi S, Sari-Minodier I, Baciuchka-Palmaro M, Botta A,
Orsière T. Exposure to genotoxic agents, host factors, and lifestyle influence
the number of centromeric signals in micronuclei: a pooled re-analysis. Mutat
Res. 2007 Feb 3;615(1-2):18-27. Epub 2007 Jan 2. PubMed PMID: 17198715.
103: Fenech M, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, Knasmüller S,
Holland N. Harmonisation of the micronucleus assay in human buccal cells--a Human
Micronucleus (HUMN) project (www.humn.org) initiative commencing in 2007.
Mutagenesis. 2007 Jan;22(1):3-4. Epub 2006 Dec 9. PubMed PMID: 17158789.
104: Menardo G, Brizzolara R, Bonassi S, Marchetti A, Dante GL, Pistone C,
Marenco D, Rabellino V, Buscaglia S, Scarso R, Murialdo M, Venturino E, Marino
CE, Descalzi D, Minetti F, Bagnasco M, Pesce G. Population screening for coeliac
disease in a low prevalence area in Italy. Scand J Gastroenterol. 2006
Dec;41(12):1414-20. PubMed PMID: 17101572.
105: Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, Lazutka
J, Cebulska-Wasilewska A, Puskailerova D, Znaor A, Kelecsenyi Z, Kurtinaitis J,
Rachtan J, Forni A, Vermeulen R, Bonassi S. Chromosomal aberrations and cancer
risk: results of a cohort study from Central Europe. Am J Epidemiol. 2007 Jan
1;165(1):36-43. Epub 2006 Oct 27. PubMed PMID: 17071846.
106: Devoto G, Gallo F, Marchello C, Racchi O, Garbarini R, Bonassi S, Albalustri
G, Haupt E. Prealbumin serum concentrations as a useful tool in the assessment of
malnutrition in hospitalized patients. Clin Chem. 2006 Dec;52(12):2281-5. Epub
2006 Oct 26. PubMed PMID: 17068165.
107: Munnia A, Bonassi S, Verna A, Quaglia R, Pelucco D, Ceppi M, Neri M, Buratti
M, Taioli E, Garte S, Peluso M. Bronchial malondialdehyde DNA adducts, tobacco
smoking, and lung cancer. Free Radic Biol Med. 2006 Nov 1;41(9):1499-505. Epub
2006 Aug 12. PubMed PMID: 17023277.
108: Trodella L, De Marinis F, D'Angelillo RM, Ramella S, Cesario A, Valente S,
Nelli F, Migliorino MR, Margaritora S, Corbo GM, Porziella V, Ciresa M, Cellini
F, Bonassi S, Russo P, Cortesi E, Granone P. Induction
cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in
the multimodality treatment of unresectable stage IIIB non-small cell lung
cancer. Lung Cancer. 2006 Dec;54(3):331-8. Epub 2006 Sep 29. PubMed PMID:
27
17011065.
109: Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M,
Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A,
Fabianova E, Fucic A, Hagmar L, Joksic G, Martelli A, Migliore L, Mirkova E,
Scarfi MR, Zijno A, Norppa H, Fenech M. An increased micronucleus frequency in
peripheral blood lymphocytes predicts the risk of cancer in humans.
Carcinogenesis. 2007 Mar;28(3):625-31. Epub 2006 Sep 14. PubMed PMID: 16973674.
110: Norppa H, Bonassi S, Hansteen IL, Hagmar L, Strömberg U, Rössner P, Boffetta
P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabiánová E, Srám RJ,
Knudsen LE, Barale R, Fucic A. Chromosomal aberrations and SCEs as biomarkers of
cancer risk. Mutat Res. 2006 Aug 30;600(1-2):37-45. Epub 2006 Jul 11. Review.
111: Kirsch-Volders M, Mateuca RA, Roelants M, Tremp A, Zeiger E, Bonassi S,
Holland N, Chang WP, Aka PV, Deboeck M, Godderis L, Haufroid V, Ishikawa H,
Laffon B, Marcos R, Migliore L, Norppa H, Teixeira JP, Zijno A, Fenech M. The
effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human
lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1038-42.
112: Massimo LM, Wiley TJ, Bonassi S, Caprino D. Longitudinal psychosocial
outcomes in two cohorts of adult survivors from childhood acute leukemia treated
with or without cranial radiation. Minerva Pediatr. 2006 Feb;58(1):1-7. PubMed
PMID: 16541001.
113: Ugolini D, Neri M, Knudsen LE, Bonassi S, Merlo DF. Searching PubMed for
molecular epidemiology studies: the case of chromosome aberrations. Environ Mol
Mutagen. 2006 May;47(4):227-9. PubMed PMID: 16416429.
114: Coco S, Defferrari R, Scaruffi P, Cavazzana A, Di Cristofano C, Longo L,
Mazzocco K, Perri P, Gambini C, Moretti S, Bonassi S, Tonini GP. Genome analysis
and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal
differences between neuroblastic and Schwannian stromal cells. J Pathol. 2005
Nov;207(3):346-57. PubMed PMID: 16178058.
115: Neri M, Ceppi M, Knudsen LE, Merlo DF, Barale R, Puntoni R, Bonassi S.
Baseline micronuclei frequency in children: estimates from meta- and pooled
analyses. Environ Health Perspect. 2005 Sep;113(9):1226-9. PubMed PMID: 16140632;
116: Banelli B, Gelvi I, Di Vinci A, Scaruffi P, Casciano I, Allemanni G, Bonassi
S, Tonini GP, Romani M. Distinct CpG methylation profiles characterize different
28
clinical groups of neuroblastic tumors. Oncogene. 2005 Aug 25;24(36):5619-28.
117: Neri M, Ugolini D, Bonassi S, Fucic A, Holland N, Knudsen LE, Srám RJ, Ceppi
M, Bocchini V, Merlo DF. Children's exposure to environmental pollutants and
biomarkers of genetic damage. II. Results of a comprehensive literature search
and meta-analysis. Mutat Res. 2006 Jan;612(1):14-39. Epub 2005 Jul 18. PubMed
PMID: 16027031.
118: Neri M, Bonassi S, Knudsen LE, Sram RJ, Holland N, Ugolini D, Merlo DF.
Children's exposure to environmental pollutants and biomarkers of genetic damage.
I. Overview and critical issues. Mutat Res. 2006 Jan;612(1):1-13. Epub 2005 Jul
5. Review. PubMed PMID: 16002329.
119: Neri M, Filiberti R, Taioli E, Garte S, Paracchini V, Bolognesi C, Canessa
PA, Fontana V, Ivaldi GP, Verna A, Bonassi S, Puntoni R. Pleural malignant
mesothelioma, genetic susceptibility and asbestos exposure. Mutat Res. 2005 Dec
30;592(1-2):36-44. Epub 2005 Jul 1. PubMed PMID: 15993904.
120: Banelli B, Di Vinci A, Gelvi I, Casciano I, Allemanni G, Bonassi S, Romani
M. DNA methylation in neuroblastic tumors. Cancer Lett. 2005 Oct
18;228(1-2):37-41. Review. PubMed PMID: 15923079.
121: Rossner P, Boffetta P, Ceppi M, Bonassi S, Smerhovsky Z, Landa K, Juzova D,
Srám RJ. Chromosomal aberrations in lymphocytes of healthy subjects and risk of
cancer. Environ Health Perspect. 2005 May;113(5):517-20. PubMed PMID: 15866756;
122: Fenech M, Baghurst P, Luderer W, Turner J, Record S, Ceppi M, Bonassi S. Low
intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and
high intake of pantothenic acid, biotin and riboflavin are significantly
associated with increased genome instability--results from a dietary intake and
micronucleus index survey in South Australia. Carcinogenesis. 2005
May;26(5):991-9. Epub 2005 Feb 10. PubMed PMID: 15705599.
123: Bonassi S, Ugolini D, Kirsch-Volders M, Strömberg U, Vermeulen R, Tucker JD.
Human population studies with cytogenetic biomarkers: review of the literature
and future prospectives. Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):258-70.
124: Scaruffi P, Parodi S, Mazzocco K, Defferrari R, Fontana V, Bonassi S, Tonini
GP. Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by
cDNA microarray comparative genomic hybridization. Mol Diagn. 2004;8(2):93-100.
29
125: Peluso M, Neri M, Margarino G, Mereu C, Munnia A, Ceppi M, Buratti M,
Felletti R, Stea F, Quaglia R, Puntoni R, Taioli E, Garte S, Bonassi S.
Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa
of cigarette smokers and interaction with metabolic gene polymorphisms.
Carcinogenesis. 2004 Dec;25(12):2459-65. Epub 2004 Aug 19. PubMed PMID: 15319297.
126: Bonassi S, Znaor A, Norppa H, Hagmar L. Chromosomal aberrations and risk of
cancer in humans: an epidemiologic perspective. Cytogenet Genome Res.
127: Toraason M, Albertini R, Bayard S, Bigbee W, Blair A, Boffetta P, Bonassi S,
Chanock S, Christiani D, Eastmond D, Hanash S, Henry C, Kadlubar F, Mirer F,
Nebert D, Rapport S, Rest K, Rothman N, Ruder A, Savage R, Schulte P, Siemiatycki
J, Shields P, Smith M, Tolbert P, Vermeulen R, Vineis P, Wacholder S, Ward E,
Waters M, Weston A. Applying new biotechnologies to the study of occupational
cancer--a workshop summary. Environ Health Perspect. 2004 Mar;112(4):413-6.
PubMed PMID: 15033588; PubMed Central PMCID: PMC1241892.
128: Hagmar L, Strömberg U, Bonassi S, Hansteen IL, Knudsen LE, Lindholm C,
Norppa H. Impact of types of lymphocyte chromosomal aberrations on human cancer
risk: results from Nordic and Italian cohorts. Cancer Res. 2004 Mar
15;64(6):2258-63. PubMed PMID: 15026371.
129: Bonassi S, Lando C, Ceppi M, Landi S, Rossi AM, Barale R. No association
between increased levels of high-frequency sister chromatid exchange cells (HFCs)
and the risk of cancer in healthy individuals. Environ Mol Mutagen.
2004;43(2):134-6. PubMed PMID: 14991754.
130: Puntoni R, Filiberti R, Cerrano PG, Neri M, Andreatta R, Bonassi S.
Implementation of a molecular epidemiology approach to human pleural malignant
mesothelioma. Mutat Res. 2003 Nov;544(2-3):385-96. Review. PubMed PMID: 14644341.
131: Neri M, Fucic A, Knudsen LE, Lando C, Merlo F, Bonassi S. Micronuclei
frequency in children exposed to environmental mutagens: a review. Mutat Res.
2003 Nov;544(2-3):243-54. Review. PubMed PMID: 14644326.
132: Hadjidekova VB, Bulanova M, Bonassi S, Neri M. Micronucleus frequency is
increased in peripheral blood lymphocytes of nuclear power plant workers. Radiat
Res. 2003 Dec;160(6):684-90. PubMed PMID: 14640795.
133: Parodi S, Muselli M, Fontana V, Bonassi S. ROC curves are a suitable and
flexible tool for the analysis of gene expression profiles. Cytogenet Genome Res.
2003;101(1):90-1. PubMed PMID: 14571143.
30
134: Cotellessa M, Barbieri P, Mazzella M, Bonassi S, Minicucci L, Lorini R. High
incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998.
Diabetes Care. 2003 Jun;26(6):1786-9. PubMed PMID: 12766110.
135: Taioli E, Bonassi S. Pooled analysis of epidemiological studies involving
biological markers. Int J Hyg Environ Health. 2003 Mar;206(2):109-15. PubMed
PMID: 12708232.
136: Bonassi S, Neri M, Lando C, Ceppi M, Lin YP, Chang WP, Holland N,
Kirsch-Volders M, Zeiger E, Fenech M; HUMN collaborative group. Effect of smoking
habit on the frequency of micronuclei in human lymphocytes: results from the
Human MicroNucleus project. Mutat Res. 2003 Mar;543(2):155-66. PubMed PMID:
12644185.
137: Tinnerberg H, Heikkilä P, Huici-Montagud A, Bernal F, Forni A, Wanders S,
Welinder H, Wilhardt P, Strömberg U, Norppa H, Knudsen L, Bonassi S, Hagmar L.
Retrospective exposure assessment and quality control in an international
multi-centre case-control study. Ann Occup Hyg. 2003 Jan;47(1):37-47. PubMed
PMID: 12505905.
138: Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E; HUman
MicronNucleus project. HUMN project: detailed description of the scoring criteria
for the cytokinesis-block micronucleus assay using isolated human lymphocyte
cultures. Mutat Res. 2003 Jan 10;534(1-2):65-75. PubMed PMID: 12504755.
139: Fenech M, Bonassi S, Turner J, Lando C, Ceppi M, Chang WP, Holland N,
Kirsch-Volders M, Zeiger E, Bigatti MP, Bolognesi C, Cao J, De Luca G, Di Giorgio
M, Ferguson LR, Fucic A, Lima OG, Hadjidekova VV, Hrelia P, Jaworska A, Joksic G,
Krishnaja AP, Lee TK, Martelli A, McKay MJ, Migliore L, Mirkova E, Müller WU,
Odagiri Y, Orsiere T, Scarfì MR, Silva MJ, Sofuni T, Surralles J, Trenta G,
Vorobtsova I, Vral A, Zijno A; HUman MicroNucleus project. Intra- and
inter-laboratory variation in the scoring of micronuclei and nucleoplasmic
bridges in binucleated human lymphocytes. Results of an international
slide-scoring exercise by the HUMN project. Mutat Res. 2003 Jan
10;534(1-2):45-64.
140: Taioli E, Bonassi S. Methodological issues in pooled analysis of biomarker
studies. Mutat Res. 2002 Sep;512(1):85-92. Review. PubMed PMID: 12220591.
141: Bonassi S, Au WW. Biomarkers in molecular epidemiology studies for health
risk prediction. Mutat Res. 2002 Mar;511(1):73-86. Review. PubMed PMID: 11906843.
142: Durante M, Bonassi S, George K, Cucinotta FA. Risk estimation based on
31
chromosomal aberrations induced by radiation. Radiat Res. 2001 Nov;156(5 Pt
2):662-7. PubMed PMID: 11604089.
143: Bonassi S, Neri M, Puntoni R. Validation of biomarkers as early predictors
of disease. Mutat Res. 2001 Sep 1;480-481:349-58. Review. PubMed PMID: 11506827.
144: Bonassi S, Fenech M, Lando C, Lin YP, Ceppi M, Chang WP, Holland N,
Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Jia C, Di
Giorgio M, Ferguson LR, Fucic A, Lima OG, Hrelia P, Krishnaja AP, Lee TK,
Migliore L, Mikhalevich L, Mirkova E, Mosesso P, Müller WU, Odagiri Y, Scarffi
MR, Szabova E, Vorobtsova I, Vral A, Zijno A. HUman MicroNucleus project:
international database comparison for results with the cytokinesis-block
micronucleus assay in human lymphocytes: I. Effect of laboratory protocol,
scoring criteria, and host factors on the frequency of micronuclei. Environ Mol
Mutagen. 2001;37(1):31-45. PubMed PMID: 11170240.
145: Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A,
Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H. Chromosomal
aberrations in lymphocytes predict human cancer independently of exposure to
carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer
Res. 2000 Mar 15;60(6):1619-25. PubMed PMID: 10749131.
146: Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The HUman MicroNucleus
Project--An international collaborative study on the use of the micronucleus
technique for measuring DNA damage in humans. Mutat Res. 1999 Jul
147: Bonassi S. Combining environmental exposure and genetic effect measurements
in health outcome assessment. Mutat Res. 1999 Jul 16;428(1-2):177-85. PubMed
PMID: 10517991.
148: Bolognesi C, Lando C, Forni A, Landini E, Scarpato R, Migliore L, Bonassi S.
Chromosomal damage and ageing: effect on micronuclei frequency in peripheral
blood lymphocytes. Age Ageing. 1999 Jul;28(4):393-7. PubMed PMID: 10459794.
149: Hagmar L, Bonassi S, Strömberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud
AH, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brøgger A, Forni A, Högstedt
B, Lambert B, Mitelman F, Nordenson I, Salomaa S, Skerfving S. Cancer predictive
value of cytogenetic markers used in occupational health surveillance programs.
Recent Results Cancer Res. 1998;154:177-84. Review. PubMed PMID: 10026999.
150: Bonassi S, Fontana V, Ceppi M, Barale R, Biggeri A. Analysis of correlated
data in human biomonitoring studies. The case of high sister chromatid exchange
frequency cells. Mutat Res. 1999 Jan 2;438(1):13-21. PubMed PMID: 9858669.
32
151: Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen LE, Norppa H,
Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: a
report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).
Cancer Res. 1998 Sep 15;58(18):4117-21. PubMed PMID: 9751622.
152: Hagmar L, Bonassi S, Strömberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud
AH, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brogger A, Forni A, Högstedt
B, Lambert B, Mitelman F, Nordenson I, Salomaa S, Skerfving S. Cancer predictive
value of cytogenetic markers used in occupational health surveillance programs: a
report from an ongoing study by the European Study Group on Cytogenetic
Biomarkers and Health. Mutat Res. 1998 Sep 20;405(2):171-8. PubMed PMID: 9748557.
153: Miele M, Bonassi S, Bonatti S, Martini E, Miglio L, Ottaggio L, Queirolo P,
Sertoli M, Abbondandolo A. Micronucleus analysis in peripheral blood lymphocytes
from melanoma patients treated with dacarbazine. Anticancer Res. 1998
May-Jun;18(3B):1967-71. PubMed PMID: 9677451.
154: Lando C, Hagmar L, Bonassi S. [Biomarkers of cytogenetic damage in humans
and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health
(ESCH)]. Med Lav. 1998 Mar-Apr;89(2):124-31. Italian. PubMed PMID: 9673102.
155: Redaelli A, Magrassi R, Bonassi S, Abbondandolo A, Frosina G. AP
endonuclease activity in humans: development of a simple assay and analysis of
ten normal individuals. Teratog Carcinog Mutagen. 1998;18(1):17-26. PubMed PMID:
9586767.
156: Pagano G, Bonassi S, De Biase A, Degan P, Deeva IB, Doronin YK, Iaccarino M,
Oral R, Warnau M, Korkina LG. L-methionine induces stage-dependent changes of
differentiation and oxidative activity in sea urchin embryogenesis. Pharmacol
Toxicol. 1997 Sep;81(3):134-43. PubMed PMID: 9335071.
157: Montanaro F, Ceppi M, Demers PA, Puntoni R, Bonassi S. Mortality in a cohort
of tannery workers. Occup Environ Med. 1997 Aug;54(8):588-91. PubMed PMID:
158: Bolognesi C, Abbondandolo A, Barale R, Casalone R, Dalprà L, De Ferrari M,
Degrassi F, Forni A, Lamberti L, Lando C, Migliore L, Padovani P, Pasquini R,
Puntoni R, Sbrana I, Stella M, Bonassi S. Age-related increase of baseline
frequencies of sister chromatid exchanges, chromosome aberrations, and
micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev. 1997
Apr;6(4):249-56. Review. PubMed PMID: 9107430.
159: Bonassi S, Forni A, Bigatti P, Canevarollo N, De Ferrari M, Lando C,
33
Padovani P, Bevegni M, Stella M, Vecchio D, Puntoni R. Chromosome aberrations in
hospital workers: evidence from surveillance studies in Italy (1963-1993). Am J
Ind Med. 1997 Mar;31(3):353-60. PubMed PMID: 9055959.
160: Peluso M, Amasio E, Bonassi S, Munnia A, Altrupa F, Parodi S. Detection of
DNA adducts in human nasal mucosa tissue by 32P-postlabeling analysis.
Carcinogenesis. 1997 Feb;18(2):339-44. PubMed PMID: 9054626.
161: Campomenosi P, Ottaggio L, Moro F, Urbini S, Bogliolo M, Zunino A, Camoriano
A, Inga A, Gentile SL, Pellegata NS, Bonassi S, Bruzzone E, Iannone R, Pisani R,
Menichini P, Ranzani GN, Bonatti S, Abbondandolo A, Fronza G. Study on aneuploidy
and p53 mutations in astrocytomas. Cancer Genet Cytogenet. 1996 Jun;88(2):95-102.
162: Bonassi S, Montanaro F, Ceppi M, Abbondandolo A. Is human exposure to
styrene a cause of cytogenetic damage? A re-analysis of the available evidence.
Biomarkers. 1996;1(4):217-25. doi: 10.3109/13547509609079361. PubMed PMID:
23888988.
163: Bonassi S, Bolognesi C, Abbondandolo A, Barale R, Bigatti P, Camurri L,
Dalpra L, De Ferrari M, Forni A, Lando C, et al. Influence of sex on cytogenetic
end points: evidence from a large human sample and review of the literature.
Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):671-9. Review. PubMed PMID:
8547835.
164: Artuso M, Angotzi G, Bonassi S, Bonatti S, De Ferrari M, Gargano D,
Lastrucci L, Miligi L, Sbrana C, Abbondandolo A. Cytogenetic biomonitoring of
styrene-exposed plastic boat builders. Arch Environ Contam Toxicol. 1995
Aug;29(2):270-4. PubMed PMID: 7661632.
165: Puntoni R, Toninelli F, Zhankui L, Bonassi S. Mathematical modelling in
risk/exposure assessment of tobacco related lung cancer. Carcinogenesis. 1995
Jul;16(7):1465-71. PubMed PMID: 7614679.
166: Degan P, Bonassi S, De Caterina M, Korkina LG, Pinto L, Scopacasa F,
Zatterale A, Calzone R, Pagano G. In vivo accumulation of
8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen
species in Fanconi's anaemia families. Carcinogenesis. 1995 Apr;16(4):735-41.
167: Bonassi S, Abbondandolo A, Camurri L, Dal Prá L, De Ferrari M, Degrassi F,
Forni A, Lamberti L, Lando C, Padovani P, et al. Are chromosome aberrations in
circulating lymphocytes predictive of future cancer onset in humans? Preliminary
results of an Italian cohort study. Cancer Genet Cytogenet. 1995 Feb;79(2):133-5.
34
168: Filiberti R, Kubík A, Reissigová J, Merlo F, Bonassi S. Cancer,
cardiovascular mortality, and diet in Italy and the Czech Republic. Neoplasma.
1995;42(5):275-83. PubMed PMID: 8552209.
169: Mazzella M, Cotellessa M, Bonassi S, Mulas R, Caratozzolo A, Gaber S, Romano
C. Incidence of type I diabetes in the Liguria Region, Italy. Results of a
prospective study in a 0- to 14-year age-group. Diabetes Care. 1994
Oct;17(10):1193-6. PubMed PMID: 7821142.
170: Bonassi S, Magnani M, Calvi A, Repetto E, Puglisi P, Pantarotto F, Lazzaroni
F. Factors related to drug consumption during pregnancy. Acta Obstet Gynecol
Scand. 1994 Aug;73(7):535-40. PubMed PMID: 8079603.
171: Bonassi S, Ceppi M, Fontana V, Merlo F. Multiple regression analysis of
cytogenetic human data. Mutat Res. 1994 Aug;313(1):69-80. PubMed PMID: 7519312.
172: Lazzaroni F, Bonassi S, Magnani M, Calvi A, Repetto E, Serra F, Podestà F,
Pearce N. Moderate maternal drinking and outcome of pregnancy. Eur J Epidemiol.
1993 Nov;9(6):599-606. PubMed PMID: 8150062.
173: Toma S, Venturino A, Sogno G, Formica C, Bignotti B, Bonassi S, Palumbo R.
Metastatic bone tumors. Nonsurgical treatment. Outcome and survival. Clin Orthop
Relat Res. 1993 Oct;(295):246-51. PubMed PMID: 8403656.
174: Bolognesi C, Parrini M, Merlo F, Bonassi S. Frequency of micronuclei in
lymphocytes from a group of floriculturists exposed to pesticides. J Toxicol
Environ Health. 1993 Oct-Nov;40(2-3):405-11. PubMed PMID: 8230311.
175: Kubík A, Bonassi S, Filiberti R, Reissigová J. Regional and national
variation in lung cancer mortality in Italy and Czechoslovakia. Eur J Cancer
Prev. 1993 Jul;2(4):337-44. PubMed PMID: 8358286.
176: Bolognesi C, Parrini M, Bonassi S, Ianello G, Salanitto A. Cytogenetic
analysis of a human population occupationally exposed to pesticides. Mutat Res.
1993 Feb;285(2):239-49. PubMed PMID: 7678897.
177: Bolognesi C, Parrini M, Reggiardo G, Merlo F, Bonassi S. Biomonitoring of
workers exposed to pesticides. Int Arch Occup Environ Health. 1993;65(1
Suppl):S185-7. PubMed PMID: 8406923.
178: Lazzaroni F, Bonassi S, Magnani M, Puglisi P, Salomone P, Pantarotto F,
Mazzeo P, Cotelessa G, Norelli MT, Santi F, et al. [Alcohol in pregnancy and
35
fetal health]. Minerva Pediatr. 1993 Jan-Feb;45(1-2):47-53. Review. Italian.
179: Lazzaroni F, Bonassi S, Magnani M, Puglisi P, Salomone P, Pantarotto F,
Mazzeo P, Cotelessa G, Norelli MT, Santi F, et al. [Effects of moderate maternal
drinking on some neonatal parameters]. Minerva Pediatr. 1992 Oct;44(10):511-7.
Italian. PubMed PMID: 1287437.
180: Lattere M, Rosati U, Chiossi M, Facco F, Magnani M, Calvi A, Renna S,
Bonassi S. [The pediatric emergency department: assessment of clinical activity
and interaction with local health authorities]. Minerva Pediatr. 1992
Sep;44(9):407-12. Italian. PubMed PMID: 1474968.
181: Facco F, Grazi G, Bonassi S, Magnani M, Di Pietro P. Chlamydial and
rickettsial transmission through tick bite in children. Lancet. 1992 Apr
18;339(8799):992-3. PubMed PMID: 1348825.
182: Toma S, Leonessa F, Romanini A, Badellino F, Bonassi S, Nicolo G, Rosso R.
Predictive value of some clinical and pathological parameters on upper level
axillary lymph node involvement in breast cancer. Anticancer Res. 1991
Jul-Aug;11(4):1439-43. PubMed PMID: 1746901.
183: De Ferrari M, Artuso M, Bonassi S, Bonatti S, Cavalieri Z, Pescatore D,
Marchini E, Pisano V, Abbondandolo A. Cytogenetic biomonitoring of an Italian
population exposed to pesticides: chromosome aberration and sister-chromatid
exchange analysis in peripheral blood lymphocytes. Mutat Res. 1991
May;260(1):105-13. PubMed PMID: 2027334.
184: Lazzaroni F, Bonassi S, Manniello E, Morcaldi L, Repetto E, Ruocco A, Calvi
A, Cotellessa G. Effect of passive smoking during pregnancy on selected perinatal
parameters. Int J Epidemiol. 1990 Dec;19(4):960-6. PubMed PMID: 2084028.
185: Bonassi S, Merlo F, Puntoni R, Ferraris F, Bottura G. [Epidemics of lung
tumors in a Biella tannery]. Epidemiol Prev. 1990 Sep;12(44):25-30. Italian.
186: Cafiero F, Gipponi M, Bonalumi U, Vecchio C, Bonassi S, Bertoglio S, Mereu
P, Percivale P. [Pre-operative identification of patients at risk for septic
complications after surgery for neoplasms of the digestive system. A multiphasic
multicenter study]. Minerva Chir. 1989 Oct 31;44(20):2169-80. Italian. PubMed
PMID: 2695858.
187: Bonassi S, Merlo F, Pearce N, Puntoni R. Bladder cancer and occupational
exposure to polycyclic aromatic hydrocarbons. Int J Cancer. 1989 Oct
36
15;44(4):648-51. PubMed PMID: 2793238.
188: Puntoni R, Goldsmith DF, Valerio F, Vercelli M, Bonassi S, Di Giorgio F,
Ceppi M, Stagnaro E, Filiberti R, Santi L, et al. A cohort study of workers
employed in a refractory brick plant. Tumori. 1988 Feb 29;74(1):27-33. PubMed
PMID: 2832986.
189: Puntoni R, Bolognesi C, Bonassi S, Merlo F, Mari A, Merialdo G, Santi L.
Cancer risk evaluation in an area with a high density of chemical plants. An
interdisciplinary approach. Ann N Y Acad Sci. 1988;534:808-16. Review. PubMed
PMID: 3291728.
190: De Ambrosis A, Ferrari N, Bonassi S, Vidali G. Nucleosomal repeat length in
active and inactive genes. FEBS Lett. 1987 Dec 10;225(1-2):120-2. PubMed PMID:
3691798.
191: Toma S, Coialbu T, Bonassi S, Nicolò G, Rosso R. A multifactorial analysis
of different biological and clinical parameters in breast cancer. Anticancer Res.
1987 May-Jun;7(3 Pt B):401-7. PubMed PMID: 3631893.
192: Toma S, Bonassi S, Puntoni R, Nicolò G. Primary tumor site, size, patients
age and axillary lymph nodes in breast cancers. Tumori. 1986 Jun 30;72(3):259-65.
193: Gipponi M, Sciutto C, Accornero L, Bonassi S, Raso C, Vignolo C, Cafiero F.
Assessing modifications of the intestinal bacterial flora in patients on
long-term oral treatment with bacampicillin or amoxicillin: a random study.
Chemioterapia. 1985 Jun;4(3):214-7. PubMed PMID: 4028281.
194: Bonassi S, Ceppi M, Puntoni R, Valerio F, Vercelli M, Belli S, Biocca M,
Comba P, Ticchiarelli L, Mariotti F, et al. Mortality studies of dockyard workers
(longshoremen) in Italy. Am J Ind Med. 1985;7(3):219-27. PubMed PMID: 3985014.
195: Puntoni R, Valerio A, Cresta E, Filiberti R, Bonassi S, Vercelli M.
[Mortality among workers in a tannery]. Med Lav. 1984 Nov-Dec;75(6):471-7.
Italian. PubMed PMID: 6533447.
Roma, 20 maggio 2015
37

CV Bonassi

Transcript

Documenti analoghi

Maria Christina Cox 23/02/1963 Dirigente medico I livello Azienda

n. 41 Settembre 2015

calcificazione vascolare

2008

Scarica CV - Fondazione Salvatore Maugeri

Scarica il CV - Cergas Bocconi

vecchione francesca - Ospedale San Gerardo

come accedere ai full text degli articoli?

Ravegnani Giuseppe Marcello